The brands are worth analyzing; the common-equity cushion is thin. Fiscal 2026 adjusted EBITDA barely stayed positive despite a tariff refund, and inventory reductions supported operating cash. Our $2 base value assumes a real recovery, while the capital-raising review leaves dilution and funding terms unresolved. We want recurring cash generation and a safer financing path before paying for a successful turnaround.
Judgmental 12-month outcomes, conditional on a multi-year operating recovery. These probabilities are not statistical forecasts.
| Measure | Value |
|---|---|
| Bear | 0.25 |
| Base | 2.00 |
| Bull | 5.00 |
| Weighted value | 1.99 |
| Snapshot price | 2.96 |
| Scenario | Probability | 12-month value | vs $2.96 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 35% | $0.25 | −92% | Weak demand persists, lenders retain the bargaining power, and common holders receive little of a financing or asset-sale recovery. Further dilution could produce a lower result. | Analyst scenario price $0.25 × 64.098M existing shares + $127.6M modeled net debt implies $143.7M enterprise value. Financing terms and share count can change; this is a scenario assumption, not a quoted transaction value. |
| Base | 45% | $2.00 | −32% | The business survives its seasonal funding cycle and rebuilds cash generation, but central costs absorb much of the brand value. Financing is available without a major unexpected dilution. | Analyst scenario price $2.00 × 64.098M existing shares + $127.6M modeled net debt implies $255.8M enterprise value. Financing terms and share count can change; this is a scenario assumption, not a quoted transaction value. |
| Bull | 20% | $5.00 | +69% | Customer retention and marketing productivity recover, Gourmet restores operating leverage, and financing terms preserve common-equity participation. | Analyst scenario price $5.00 × 64.098M existing shares + $127.6M modeled net debt implies $448.1M enterprise value. Financing terms and share count can change; this is a scenario assumption, not a quoted transaction value. |
| Probability-weighted value: $1.99. Base fair value $2.00, working range $1.50–$2.50. The range is a valuation band, not a confidence interval or a floor in financial distress. | |||||
| Signpost | Now (Q4 FY2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| FY2027 adjusted EBITDA | Guide $10–15M | Above $15M without new refunds/add-backs | Below $10M or guide withdrawn | Next report, expected fall2026; FY2027 annual review |
| Recurring demand | Q4 consolidated revenue −12.9% | Decline narrows to less than5% | Decline remains worse than10% | Next quarterly release, expected fall2026 |
| Order volume | Q3 e-commerce orders −18.5% | Order decline narrows to less than5% | More than15% decline persists | Next disclosed order KPI; fall2026/early2027 |
| Annual free cash flow | FY2026 −$13.0M | Positive full-year FCF with stable inventory | Another annual cash outflow | FY2027 year-end release, expected2027 |
| Corporate burden | Comparable FY2026 $125.6M | Below $110M with service quality intact | Above $130M while revenue falls | FY2027 interim trends and annual report |
| Financing and dilution | Capital options under evaluation | Funding disclosed without material dilution | More than10% share issuance or worsening liquidity | Next financing filing; review by Dec31,2026 |
| Refund dependence | ~$7M Q4 benefit | Positive EBITDA excluding material refunds | Refunds again determine profitability | Next earnings reconciliation, expected fall2026 |
Thresholds are Charged Alpha monitoring rules, not management promises. Expected reporting windows are estimates. At the next packet, grade these same tests before changing the thesis.
A low share price still embeds a substantial operating recovery.
The reference quote is $2.96 from the saved September10 intraday snapshot, compared with the preceding close of $3.49. That is a computed -15.3% move. The session was still open, so neither this number nor the provider’s same-day “close” field is presented as a final closing return. The chart below deliberately stops at the last completed trading day. This distinction matters when a volatile, relatively small company can move substantially while an episode is being researched.
The stock is not automatically inexpensive because the share price is low. Equity receives the residual after lenders and other obligations, and the company is actively evaluating ways to bring capital into the business. A successful transaction can stabilize operations while giving existing shareholders less of the eventual recovery. We therefore compare the price with explicit enterprise-value assumptions and a full dual-class share count, rather than treating the market capitalization as the cost of buying the operating business.
| Date | Close |
|---|---|
| 2025-06-10 | $5.16 |
| 2025-06-11 | $5.10 |
| 2025-06-12 | $5.10 |
| 2025-06-13 | $4.97 |
| 2025-06-16 | $5.12 |
| 2025-06-17 | $5.12 |
| 2025-06-18 | $5.16 |
| 2025-06-20 | $5.12 |
| 2025-06-23 | $5.01 |
| 2025-06-24 | $5.06 |
| 2025-06-25 | $4.92 |
| 2025-06-26 | $5.15 |
| 2025-06-27 | $5.13 |
| 2025-06-30 | $4.92 |
| 2025-07-01 | $5.36 |
| 2025-07-02 | $5.48 |
| 2025-07-03 | $5.61 |
| 2025-07-07 | $5.42 |
| 2025-07-08 | $5.60 |
| 2025-07-09 | $5.70 |
| 2025-07-10 | $5.73 |
| 2025-07-11 | $5.62 |
| 2025-07-14 | $5.62 |
| 2025-07-15 | $5.43 |
| 2025-07-16 | $5.40 |
| 2025-07-17 | $5.39 |
| 2025-07-18 | $5.15 |
| 2025-07-21 | $5.16 |
| 2025-07-22 | $6.65 |
| 2025-07-23 | $6.94 |
| 2025-07-24 | $6.26 |
| 2025-07-25 | $6.38 |
| 2025-07-28 | $6.80 |
| 2025-07-29 | $6.27 |
| 2025-07-30 | $5.90 |
| 2025-07-31 | $5.91 |
| 2025-08-01 | $5.38 |
| 2025-08-04 | $5.62 |
| 2025-08-05 | $5.85 |
| 2025-08-06 | $5.95 |
| 2025-08-07 | $5.59 |
| 2025-08-08 | $5.54 |
| 2025-08-11 | $5.44 |
| 2025-08-12 | $5.53 |
| 2025-08-13 | $5.72 |
| 2025-08-14 | $5.55 |
| 2025-08-15 | $5.46 |
| 2025-08-18 | $5.57 |
| 2025-08-19 | $5.46 |
| 2025-08-20 | $5.50 |
| 2025-08-21 | $5.38 |
| 2025-08-22 | $5.39 |
| 2025-08-25 | $5.38 |
| 2025-08-26 | $5.65 |
| 2025-08-27 | $5.60 |
| 2025-08-28 | $5.60 |
| 2025-08-29 | $5.60 |
| 2025-09-02 | $5.58 |
| 2025-09-03 | $5.33 |
| 2025-09-04 | $5.18 |
| 2025-09-05 | $5.10 |
| 2025-09-08 | $4.97 |
| 2025-09-09 | $5.09 |
| 2025-09-10 | $5.12 |
| 2025-09-11 | $5.26 |
| 2025-09-12 | $5.39 |
| 2025-09-15 | $5.43 |
| 2025-09-16 | $5.33 |
| 2025-09-17 | $5.25 |
| 2025-09-18 | $5.65 |
| 2025-09-19 | $5.54 |
| 2025-09-22 | $5.40 |
| 2025-09-23 | $5.04 |
| 2025-09-24 | $4.85 |
| 2025-09-25 | $4.72 |
| 2025-09-26 | $4.77 |
| 2025-09-29 | $4.86 |
| 2025-09-30 | $4.60 |
| 2025-10-01 | $4.55 |
| 2025-10-02 | $4.58 |
| 2025-10-03 | $4.58 |
| 2025-10-06 | $4.41 |
| 2025-10-07 | $4.40 |
| 2025-10-08 | $4.61 |
| 2025-10-09 | $4.45 |
| 2025-10-10 | $4.22 |
| 2025-10-13 | $4.31 |
| 2025-10-14 | $4.32 |
| 2025-10-15 | $4.33 |
| 2025-10-16 | $4.39 |
| 2025-10-17 | $4.50 |
| 2025-10-20 | $4.54 |
| 2025-10-21 | $5.15 |
| 2025-10-22 | $4.39 |
| 2025-10-23 | $4.76 |
| 2025-10-24 | $4.87 |
| 2025-10-27 | $3.89 |
| 2025-10-28 | $3.67 |
| 2025-10-29 | $3.49 |
| 2025-10-30 | $3.62 |
| 2025-10-31 | $3.60 |
| 2025-11-03 | $3.54 |
| 2025-11-04 | $3.39 |
| 2025-11-05 | $3.49 |
| 2025-11-06 | $3.41 |
| 2025-11-07 | $3.49 |
| 2025-11-10 | $3.29 |
| 2025-11-11 | $3.24 |
| 2025-11-12 | $3.20 |
| 2025-11-13 | $3.10 |
| 2025-11-14 | $3.19 |
| 2025-11-17 | $3.20 |
| 2025-11-18 | $3.24 |
| 2025-11-19 | $3.26 |
| 2025-11-20 | $3.12 |
| 2025-11-21 | $3.09 |
| 2025-11-24 | $3.06 |
| 2025-11-25 | $3.26 |
| 2025-11-26 | $3.40 |
| 2025-11-28 | $3.41 |
| 2025-12-01 | $3.41 |
| 2025-12-02 | $3.44 |
| 2025-12-03 | $3.60 |
| 2025-12-04 | $3.49 |
| 2025-12-05 | $3.50 |
| 2025-12-08 | $3.72 |
| 2025-12-09 | $4.94 |
| 2025-12-10 | $4.77 |
| 2025-12-11 | $4.39 |
| 2025-12-12 | $3.91 |
| 2025-12-15 | $4.30 |
| 2025-12-16 | $4.63 |
| 2025-12-17 | $4.56 |
| 2025-12-18 | $4.47 |
| 2025-12-19 | $4.14 |
| 2025-12-22 | $3.91 |
| 2025-12-23 | $4.10 |
| 2025-12-24 | $4.13 |
| 2025-12-26 | $4.05 |
| 2025-12-29 | $3.91 |
| 2025-12-30 | $3.95 |
| 2025-12-31 | $3.93 |
| 2026-01-02 | $3.69 |
| 2026-01-05 | $3.94 |
| 2026-01-06 | $4.14 |
| 2026-01-07 | $4.30 |
| 2026-01-08 | $4.35 |
| 2026-01-09 | $4.38 |
| 2026-01-12 | $4.62 |
| 2026-01-13 | $4.46 |
| 2026-01-14 | $4.45 |
| 2026-01-15 | $4.66 |
| 2026-01-16 | $4.76 |
| 2026-01-20 | $4.46 |
| 2026-01-21 | $4.47 |
| 2026-01-22 | $4.44 |
| 2026-01-23 | $4.49 |
| 2026-01-26 | $4.38 |
| 2026-01-27 | $4.05 |
| 2026-01-28 | $4.04 |
| 2026-01-29 | $4.63 |
| 2026-01-30 | $4.32 |
| 2026-02-02 | $4.13 |
| 2026-02-03 | $3.94 |
| 2026-02-04 | $4.10 |
| 2026-02-05 | $4.02 |
| 2026-02-06 | $4.06 |
| 2026-02-09 | $4.07 |
| 2026-02-10 | $4.25 |
| 2026-02-11 | $4.09 |
| 2026-02-12 | $3.69 |
| 2026-02-13 | $3.56 |
| 2026-02-17 | $3.41 |
| 2026-02-18 | $3.30 |
| 2026-02-19 | $3.28 |
| 2026-02-20 | $3.28 |
| 2026-02-23 | $3.23 |
| 2026-02-24 | $3.31 |
| 2026-02-25 | $3.34 |
| 2026-02-26 | $3.58 |
| 2026-02-27 | $3.48 |
| 2026-03-02 | $3.41 |
| 2026-03-03 | $3.38 |
| 2026-03-04 | $3.46 |
| 2026-03-05 | $3.54 |
| 2026-03-06 | $3.35 |
| 2026-03-09 | $3.37 |
| 2026-03-10 | $3.33 |
| 2026-03-11 | $3.31 |
| 2026-03-12 | $3.28 |
| 2026-03-13 | $3.27 |
| 2026-03-16 | $3.37 |
| 2026-03-17 | $3.34 |
| 2026-03-18 | $3.16 |
| 2026-03-19 | $3.17 |
| 2026-03-20 | $3.01 |
| 2026-03-23 | $3.13 |
| 2026-03-24 | $3.12 |
| 2026-03-25 | $3.08 |
| 2026-03-26 | $3.00 |
| 2026-03-27 | $3.10 |
| 2026-03-30 | $3.07 |
| 2026-03-31 | $3.04 |
| 2026-04-01 | $3.13 |
| 2026-04-02 | $3.22 |
| 2026-04-06 | $3.21 |
| 2026-04-07 | $3.19 |
| 2026-04-08 | $3.29 |
| 2026-04-09 | $3.42 |
| 2026-04-10 | $3.28 |
| 2026-04-13 | $3.23 |
| 2026-04-14 | $3.35 |
| 2026-04-15 | $3.56 |
| 2026-04-16 | $3.64 |
| 2026-04-17 | $3.88 |
| 2026-04-20 | $4.46 |
| 2026-04-21 | $4.00 |
| 2026-04-22 | $3.94 |
| 2026-04-23 | $3.78 |
| 2026-04-24 | $3.61 |
| 2026-04-27 | $3.79 |
| 2026-04-28 | $3.71 |
| 2026-04-29 | $3.49 |
| 2026-04-30 | $3.54 |
| 2026-05-01 | $3.72 |
| 2026-05-04 | $3.63 |
| 2026-05-05 | $3.61 |
| 2026-05-06 | $3.93 |
| 2026-05-07 | $4.58 |
| 2026-05-08 | $4.82 |
| 2026-05-11 | $4.37 |
| 2026-05-12 | $4.39 |
| 2026-05-13 | $4.27 |
| 2026-05-14 | $4.57 |
| 2026-05-15 | $4.33 |
| 2026-05-18 | $4.29 |
| 2026-05-19 | $3.95 |
| 2026-05-20 | $3.97 |
| 2026-05-21 | $4.23 |
| 2026-05-22 | $4.34 |
| 2026-05-26 | $4.39 |
| 2026-05-27 | $4.32 |
| 2026-05-28 | $4.50 |
| 2026-05-29 | $4.57 |
| 2026-06-01 | $4.56 |
| 2026-06-02 | $4.70 |
| 2026-06-03 | $4.33 |
| 2026-06-04 | $4.52 |
| 2026-06-05 | $4.34 |
| 2026-06-08 | $4.42 |
| 2026-06-09 | $4.32 |
| 2026-06-10 | $4.22 |
| 2026-06-11 | $4.23 |
| 2026-06-12 | $4.32 |
| 2026-06-15 | $4.27 |
| 2026-06-16 | $4.27 |
| 2026-06-17 | $3.87 |
| 2026-06-18 | $3.89 |
| 2026-06-22 | $3.55 |
| 2026-06-23 | $3.55 |
| 2026-06-24 | $3.63 |
| 2026-06-25 | $3.55 |
| 2026-06-26 | $3.56 |
| 2026-06-29 | $3.57 |
| 2026-06-30 | $3.48 |
| 2026-07-01 | $3.71 |
| 2026-07-02 | $3.85 |
| 2026-07-06 | $3.73 |
| 2026-07-07 | $3.77 |
| 2026-07-08 | $3.72 |
| 2026-07-09 | $3.80 |
| 2026-07-10 | $3.78 |
| 2026-07-13 | $3.88 |
| 2026-07-14 | $3.85 |
| 2026-07-15 | $3.92 |
| 2026-07-16 | $4.08 |
| 2026-07-17 | $4.11 |
| 2026-07-20 | $4.23 |
| 2026-07-21 | $4.20 |
| 2026-07-22 | $4.21 |
| 2026-07-23 | $3.89 |
| 2026-07-24 | $3.82 |
| 2026-07-27 | $3.83 |
| 2026-07-28 | $3.96 |
| 2026-07-29 | $3.93 |
| 2026-07-30 | $3.84 |
| 2026-07-31 | $3.90 |
| 2026-08-03 | $4.20 |
| 2026-08-04 | $4.13 |
| 2026-08-05 | $4.13 |
| 2026-08-06 | $4.03 |
| 2026-08-07 | $4.02 |
| 2026-08-10 | $3.98 |
| 2026-08-11 | $4.04 |
| 2026-08-12 | $4.09 |
| 2026-08-13 | $4.07 |
| 2026-08-14 | $4.08 |
| 2026-08-17 | $4.00 |
| 2026-08-18 | $4.02 |
| 2026-08-19 | $4.08 |
| 2026-08-20 | $4.02 |
| 2026-08-21 | $3.97 |
| 2026-08-24 | $3.88 |
| 2026-08-25 | $3.92 |
| 2026-08-26 | $3.74 |
| 2026-08-27 | $3.74 |
| 2026-08-28 | $3.73 |
| 2026-08-31 | $3.65 |
| 2026-09-01 | $3.44 |
| 2026-09-02 | $3.63 |
| 2026-09-03 | $3.58 |
| 2026-09-04 | $3.73 |
| 2026-09-08 | $3.65 |
| 2026-09-09 | $3.49 |
| Period | Return % |
|---|---|
| 2024 Q4 | −12.11 |
| 2025 Q1 | 3.87 |
| 2025 Q2 | −8.38 |
| 2025 Q3 | −16.06 |
| 2025 Q4 | −2.81 |
| 2026 Q1 | 3.72 |
| 2026 Q2 | 14.60 |
| 2026 Q3 | 16.54 |
| 2026 Q4 | −15.33 |
Historical reactions are useful as a volatility map, not as a trading rule. Macro news, changing expectations and the timing of the company’s own press release can all influence these windows. The research file retains each SEC acceptance time and the actual price observations. The market has already reduced the valuation, but a falling price does not tell us whether the future cash-flow assumptions are conservative enough.
Revenue weakness persists; reported and adjusted profit tell different stories.
Quarterly revenue was $293.118M, against $336.622M a year earlier. Lower spending on inefficient marketing can be a rational choice, but management still has to demonstrate that the resulting customer base is healthier and that repeat purchases can support the cost structure. A lower sales base also spreads manufacturing, fulfillment and central infrastructure across fewer orders. That operating leverage makes the direction of demand as important as a single cost-saving announcement.
| Measure | Q4 FY2026 | Q4 FY2025 | Interpretation |
|---|---|---|---|
| Revenue | $293.118M | $336.622M | Consolidated sales declined |
| Gross profit | $101.810M | $119.361M | Includes approximately $7M tariff refund this quarter |
| Operating loss | −$56.372M | −$55.479M | GAAP operations did not improve |
| Net loss | −$52.297M | −$51.907M | Below-the-line items affect comparison |
| GAAP diluted EPS | −$0.82 | −$0.82 | Rounded EPS can hide dollar movement |
| Adjusted diluted EPS | −$0.80 | −$0.69 | Issuer reconciliation; not GAAP |
| Adjusted EBITDA | −$31.017M | −$24.246M | Loss widened on adjusted basis |
| Source: issuer filings; derived measures computed in the saved research model. | |||
The vendor earnings record reports revenue consensus of $294.169M and adjusted EPS consensus of negative $0.70. Actual revenue was slightly below that snapshot and adjusted EPS was weaker. The adjusted label is essential: the filing’s GAAP diluted loss was $0.82 per share. Mixing that GAAP result with a vendor adjusted estimate would produce a false comparison. This is an expectations snapshot, not a guarantee that every covering analyst used the same assumptions or last updated at the same time.
| Period | Revenue |
|---|---|
| 2024 Q4 | 360.91 |
| 2025 Q1 | 242.09 |
| 2025 Q2 | 775.49 |
| 2025 Q3 | 331.45 |
| 2025 Q4 | 336.62 |
| 2026 Q1 | 215.20 |
| 2026 Q2 | 702.18 |
| 2026 Q3 | 293.01 |
| 2026 Q4 | 293.12 |
| Period | Growth % |
|---|---|
| 2025 Q4 | −6.73 |
| 2026 Q1 | −11.11 |
| 2026 Q2 | −9.45 |
| 2026 Q3 | −11.60 |
| 2026 Q4 | −12.92 |
Fiscal2027 guidance calls for a mid-single-digit revenue decline and $10–15M of adjusted EBITDA. We retain the company’s words for revenue instead of inventing exact upper and lower endpoints. The EBITDA outlook includes approximately $12M of additional compensation expense. It therefore contains both an operating recovery assumption and a higher compensation burden. It is not a forecast of free cash flow, GAAP earnings or cash available to repay debt.
Three useful businesses, one expensive shared infrastructure.
Consumer Floral & Gifts remains the clearest test of marketing discipline. Quarterly sales fell13.4%, yet adjusted contribution was $17.085M versus $17.403M. The business preserved much of its direct contribution despite losing substantial revenue. That supports the argument that management is removing low-quality demand. It does not prove that the customer economics will remain attractive if order volume keeps shrinking. The next test is whether contribution stability can coexist with a less severe revenue decline.
Gourmet Foods & Gift Baskets has a different problem. Quarterly revenue fell15.4%, with Easter timing also affecting the comparison, and the gross margin declined to17.7%. The company identified sales deleverage and tariff, commodity and shipping pressures. The adjusted contribution loss of $23.381M was worse than the prior-year loss of $19.023M. A seasonal food and gift operation cannot be evaluated from a weak quarter alone, but the full-year adjusted contribution also declined. Inventory procurement and holiday execution make this segment especially relevant to the financing calendar.
| Period | FY2025 | FY2026 |
|---|---|---|
| Floral & Gifts | 776.78 | 638.93 |
| BloomNet | 98.71 | 96.83 |
| Gourmet Foods | 810.94 | 768.52 |
| Period | FY2025 | FY2026 |
|---|---|---|
| Floral & Gifts | 50.46 | 48.59 |
| BloomNet | 29.27 | 27.21 |
| Gourmet Foods | 58.77 | 52.72 |
BloomNet is the relative bright spot. Quarterly sales grew1.9%, while adjusted contribution rose to$7.404M from$6.463M. Its network and services economics are valuable, but the division is much smaller than the consumer gifting businesses. A valuation that gives BloomNet an attractive multiple still has to deduct the shared costs necessary to operate the group. We treat that deduction as a central analytical requirement, not an optional conservatism adjustment.
| Period | Order change % |
|---|---|
| 2025 Q1 | −6.50 |
| 2025 Q2 | −7.20 |
| 2025 Q3 | −14.20 |
| 2026 Q1 | −14.40 |
| 2026 Q2 | −16.40 |
| 2026 Q3 | −18.50 |
The latest filed interim report showed a sharper order decline even as average order value increased. In fiscal2026 Q3, orders were down18.5% and AOV rose5.0% to$83.39. Higher ticket size can reflect mix and pricing rather than improved customer acquisition. Our preferred evidence is a narrowing order decline with stable contribution, rather than higher AOV that merely accompanies a shrinking customer pool.
Why a smaller GAAP loss is not a turnaround signal by itself.
Annual net loss improved to$134.765M from$199.993M. The reduction in goodwill and intangible impairment was larger than that improvement. Current impairment was$45.154M compared with$143.823M a year earlier. Meanwhile, adjusted net loss widened to$77.481M from$52.518M. The two statements can both be true: fewer assets were written down, while the remaining business produced worse adjusted earnings. The episode’s angle comes from that distinction.
| Item | $M |
|---|---|
| Adj EBITDA | −31.017 |
| SBC | −3.761 |
| NQDC | −6.632 |
| Restructuring | −0.723 |
| EBITDA | −42.133 |
| D&A | −14.239 |
| Net other | 3.827 |
| Tax benefit | 0.248 |
| Net loss | −52.297 |
| Item | $M |
|---|---|
| Adj EBITDA | 2.930 |
| SBC | −11.256 |
| NQDC | −7.708 |
| Restructuring | −12.312 |
| Impairment | −45.154 |
| EBITDA | −73.500 |
| D&A | −53.617 |
| Net other | −7.652 |
| Tax benefit | 0.004 |
| Net loss | −134.765 |
Adjusted EBITDA removes depreciation, interest, taxes and several other expenses. The measure can help compare operations, but it does not fund the capital expenditure needed to maintain the platform, the lender’s interest bill or scheduled principal payments. Stock compensation is also an economic cost to owners even when it is not a current cash payment. The valuation therefore does not simply capitalize the adjusted number and declare the balance-sheet burden solved.
The NQDC line needs separate care. Compensation tied to deferred-compensation investments is paired with investment gains or losses elsewhere in the accounts; ignoring one side can distort operations. The issuer excludes the compensation movement in adjusted EBITDA. We preserve its reconciliation and identify the associated other-income effect, rather than celebrating that below-the-line income as a new source of customer profitability. The approximately$7M tariff refund is another distinct item: mechanically removing it from FY2026 adjusted EBITDA produces roughly negative$4.1M, an analytical illustration rather than a new issuer metric.
Cash conversion, working capital and the cost of adjustments.
Cash quality is the most useful counterweight to adjusted earnings here. The company reported$18.308M of annual operating cash inflow, but the inventory line contributed$24.344M. Removing only that release would leave operating cash below zero. This is not a complete normalized cash-flow forecast: receivables, prepaid costs, payables and other items also moved. It is a transparent test showing that improved cash generation did not yet come solely from profitable, repeatable customer activity.
| Period | SBC | NQDC | Restructuring | Impairment |
|---|---|---|---|---|
| FY2025 | 11.89 | 5.42 | 5.82 | 143.82 |
| FY2026 | 11.26 | 7.71 | 12.31 | 45.15 |
| Period | Inventory | Receivables |
|---|---|---|
| FY2025 | 62.56 | 4.70 |
| FY2026 | 59.82 | 5.24 |
Inventory can fall because demand planning improves, because the business shrinks, or because merchandise is cleared at a less attractive margin. Those explanations have different implications for future free cash flow. We need to see stable inventory levels alongside better orders and recurring gross profit before extrapolating another large release. Receivables are relatively small, consistent with substantial card-based consumer activity; this does not eliminate the more important inventory and fulfillment risks.
The latest annual auditor opinion and subsequent interim disclosure-control conclusion are effective, which distinguishes operating stress from an identified financial-control failure. That is a necessary foundation for using the filings, not a promise about future earnings. We have not manufactured a Beneish or Altman score from incomplete or mismatched inputs. The scorecard above keeps its definitions visible and leaves unavailable measures explicitly unscored.
A seasonal credit line is not the same thing as cash in the bank.
| Period | Operating cash | Capex | Free cash flow |
|---|---|---|---|
| 2024 | 95.00 | 38.63 | 56.37 |
| 2025 | −26.36 | 41.46 | −67.83 |
| 2026 | 18.31 | 31.28 | −12.97 |
| Balance / obligation | Amount | Important limitation |
|---|---|---|
| June28 cash | $11.366M | Reporting-date balance; not today’s cash |
| Debt carrying value | $136.176M | Includes current and long-term debt, net of financing costs |
| Principal rollforward | $139.0M | Computed from prior principal and annual borrowing/repayment cash flows |
| Modeled net debt | $127.634M | Principal rollforward less cash; annual filing confirmation pending |
| Current debt maturities | $24.0M | Separate from interest and capital expenditure |
| Revolver stated commitment | $205M | Subject to covenants, seasonal reductions, usage and conditions |
| Seasonal commitment limit | $50M | Jan1–July1 during covenant-relief period |
| Monthly liquidity minimum | Not available | Referenced ScheduleI is absent from supplied embedded exhibit |
| Source: issuer filings; derived measures computed in the saved research model. | ||
The small year-end cash balance is a warning signal, but it would be wrong to turn it into a countdown to insolvency. This company builds inventory ahead of holiday demand and uses a revolving facility to bridge the cycle. The latest interim filing describes borrowings peaking at$175M in November2025 and repayment after holiday collections. Conversely, quoting the$205M headline commitment as unrestricted spare cash would be equally misleading. The agreement imposes seasonal limits and borrowing conditions, and the current exact availability is not disclosed in the examined excerpt.
| Measure | Value |
|---|---|
| Equity at snapshot | 189.41 |
| Modeled net debt | 127.63 |
| Enterprise value | 317.05 |
| Period | Cash | Net debt |
|---|---|---|
| 2024 Q4 | 159.44 | 27.68 |
| 2025 Q1 | 8.41 | 221.39 |
| 2025 Q2 | 247.22 | −89.75 |
| 2025 Q3 | 84.68 | 72.59 |
| 2025 Q4 | 46.50 | 109.26 |
| 2026 Q1 | 7.75 | 255.19 |
| 2026 Q2 | 193.34 | −45.87 |
| 2026 Q3 | 50.70 | 91.13 |
| 2026 Q4 | 11.37 | 124.81 |
The September amendment extends the liquidity-covenant framework and permits some asset-sale proceeds to remain in the business after a required term-loan prepayment. It also requires monthly lender calls. Management is evaluating debt, equity and non-strategic asset sales with an adviser, but has not announced a completed financing on defined terms. The distinction between a possible source of cash and cash already secured is central to this packet. We do not assume an asset sale occurs at book value or that an equity raise is nondilutive.
Our enterprise-value bridge uses a computed$139M principal balance, rather than the lower debt carrying amount, and subtracts actual June28 cash. That rollforward comes from$160M of prior principal plus$175M of borrowings less$196M of repayments. It will be checked against the next annual debt note. Operating lease commitments are considered through rent-bearing operating earnings and cash flows, rather than added to debt while leaving an inconsistent profit denominator. Financing costs, future dilution and any transaction fees remain sources of valuation uncertainty.
Three routes, with the cost of recovery left visible.
At the snapshot price, equity based on the dated dual-class count plus modeled net debt gives enterprise value of $317.0M. At a7x normalized EBITDA multiple, that price requires about $45.3M of EBITDA. That is substantially above the new$10–15M FY2027 guide. The market is paying for a later recovery, not merely valuing next year’s stated outlook. Our base value also assumes recovery; it simply asks for more compensation for the financing and execution risks.
Analyst FCFF assumptions are$5M,$10M,$20M,$30M,$40M across five model years, after reinvestment and economic SBC cost. At14% discount rate and2% terminal growth, explicit cash-flow present value plus terminal present value produces $240.7M enterprise value. Subtract $127.6M modeled net debt and divide by 64.098M shares. These are conditional model inputs, not company forecasts.
$40M normalized adjusted EBITDA ×7 = $280.0M enterprise value; less $127.6M net debt = $152.4M equity. Divide by 64.098M shares. The7x multiple is an analyst choice for a risky turnaround, not a measured peer average. The assumed earnings recovery is well above current guidance.
FY2026 adjusted contributions: Floral$48.586M×6; BloomNet$27.211M×8; Gourmet$52.719M×6. Deduct$100M of assumed normalized annual corporate burden capitalized at6x, then $127.6M net debt. Result: $97.9M equity divided by 64.098M shares. This assumes central costs fall from the comparable$125.586M actual burden. No brand is valued as if it operates without support costs.
The three results support a working$1.50–$2.50 range and a rounded$2 base value. They are not independent observations to average mechanically: each depends on better operating performance, available financing and the share count. We disclose that overlap rather than using three methods to create an illusion of certainty. The SOTP and EBITDA routes are rough earnings-power checks; the DCF carries reinvestment and economic stock compensation more explicitly. Their difference is part of the reason the uncertainty rating is Very High.
| EBITDA | 5x | 6x | 7x | 8x | 9x |
|---|---|---|---|---|---|
| 20 | $0.00 | $0.00 | $0.19 | $0.50 | $0.82 |
| 30 | $0.35 | $0.82 | $1.28 | $1.75 | $2.22 |
| 40 | $1.13 | $1.75 | $2.38 | $3.00 | $3.63 |
| 50 | $1.91 | $2.69 | $3.47 | $4.25 | $5.03 |
| 60 | $2.69 | $3.63 | $4.56 | $5.50 | $6.43 |
The largest sensitivity is not a small change in the discount rate. It is whether the company can fund the turnaround while preserving shareholder participation. A debt refinancing can raise interest expense. An equity raise increases the denominator. An asset sale can reduce debt but also remove contribution that supported enterprise value. We do not grant the full debt benefit of a sale while retaining all the sold earnings in the model. The announced evaluation does not provide enough terms to calculate those outcomes as facts.
Our SELL3/5 view therefore reflects insufficient protection at the snapshot price, rather than a claim that the operating brands have no value. A lower price alone would not automatically establish a BUY. We would first need evidence that the liquidity path is financeable and that cash earnings are improving without another unusual refund or working-capital release. The bear case includes severe common-equity impairment; the bull case recognizes that modest margin recovery across a large sales base can create considerable upside.
The feed is available; fresh post-print estimates are not.
The saved vendor aggregate shows eight Buy ratings, three Hold ratings and no Sell ratings, with a$9.50 average target and a$7–$12 range. These endpoints do not provide a date for each underlying contribution. The newest individual target item returned in the fetched history is from August2024. We therefore show the aggregate as a stale or undated reference and do not describe it as analysts reacting to this quarter. A large apparent upside to a stale target is not evidence that the current operating or financing risks are already priced conservatively.
| Period | Count |
|---|---|
| Buy | 8.00 |
| Hold | 3.00 |
| Sell | 0.00 |
| Source / date | Rating or target | How we use it |
|---|---|---|
| Vendor aggregate; date not supplied | Buy; $9.50 mean | Context only; no post-print freshness claim |
| D.A. Davidson; Aug30,2024 | $7; Neutral | Historical item, not a current recommendation |
| D.A. Davidson; Aug27,2024 | $8; Underperform | Historical revision context |
| Craig-Hallum; Apr28,2022 | $12 | Old record; not evidence of present coverage |
| Charged Alpha; Sep10,2026 | SELL3/5; $2 base | Current filing-based conditional valuation |
| FMP price-target and rating responses, with publication dates preserved in raw research. These are attributed provider records, not independently verified analyst reports. | ||
Both the annual and quarterly forward-estimate endpoints returned an entitlement error. We did not replace them with invented revenue or EPS paths, nor infer consensus revisions from management’s guidance. The verified quarter earnings comparison remains available separately. A future research update can add a proper consensus bridge when dated, comparable observations are available. Until then, the distinction between a provider data gap and an optimistic or pessimistic analyst view remains explicit.
| Forward measure | Management | Verified forward consensus |
|---|---|---|
| FY2027 sales | Mid-single-digit decline | Unavailable from authorized endpoint |
| FY2027 adjusted EBITDA | $10–15M | Unavailable |
| Additional compensation expense | Approximately$12M | Not a consensus comparison |
| Source: issuer filings; derived measures computed in the saved research model. | ||
Our disagreement is consequently with the price and the operating assumptions needed to justify it, not with a fabricated set of fresh analyst notes. The episode’s Wall Street slide must retain this age warning. Comparing a current distressed valuation with an undated historical target without that warning would overstate the evidence for both the bullish and bearish cases.
Judge the transformation by observable customer and cash outcomes.
Management describes investment in marketing technology, digital experience, personalization and customer retention. Those initiatives can be sensible, particularly when earlier advertising spend was inefficient. The analytical issue is the timing of the payoff relative to the financing runway. A large platform transformation can require cash before it produces better acquisition economics. The current guidance calls for another revenue decline, so we should not present the transformation as already delivering a return to growth.
| Test | Observed evidence | Assessment |
|---|---|---|
| Marketing discipline | Floral adjusted contribution nearly stable despite lower Q4 revenue | Encouraging unit discipline; demand recovery unproven |
| Cost burden | Comparable corporate expense absorbs almost all adjusted segment contribution | Further measurable efficiency required |
| Cash allocation | Annual capex$31.280M; FCF negative | Investment must earn a return before financial flexibility improves |
| Financing transparency | Covenant amendment and capital-options review disclosed | Terms and shareholder consequences still unresolved |
| Governance | Dual-class structure; ClassB carries ten votes | Economic exposure and voting influence differ |
| Reporting foundation | Latest annual and interim controls effective | Supports source reliability, not operating success |
| Source: issuer filings; derived measures computed in the saved research model. | ||
The latest annual report identifies ClassA as one vote per share and ClassB as ten, with one-for-one conversion rights subject to the described transfer rules. Our share denominator includes both economic classes. The proxy documents substantial McCann-family ownership and voting power. We do not equate the freely traded float with all shares entitled to future cash flows, and we do not imply that public minority holders have equal influence over capital-structure decisions.
Approximately3,900 full- and part-time employees were reported at June2025, with staffing rising materially in peak periods. This is the last verified annual count, not a fiscal2026 employment claim. The company historically has not paid cash dividends. The latest filed interim report showed$10.6M remaining under the repurchase authorization, but authorization is not a commitment to deploy cash. Cash used to acquire treasury shares can also include withholding-related activity; it should not automatically be described as an open-market return of capital.
The downside and the strongest counterargument both matter.
| Rank / risk | Likelihood | Impact | What changes our view |
|---|---|---|---|
| 1. Financing and dilution | High | Very High | Committed funding on disclosed terms with manageable interest and share issuance |
| 2. Persistent order decline | High | High | Several comparable periods of improved order trends and contribution |
| 3. Holiday execution / inventory | Medium–High | High | Inventory builds convert to cash without discount-led margin damage |
| 4. Corporate cost rigidity | High | High | Comparable central burden falls alongside stable customer service |
| 5. Refund and adjustment dependence | Medium–High | High | Positive earnings and cash conversion without unusual items |
| 6. Consumer and commodity pressure | Medium | High | Better demand and gross margin despite external costs |
| 7. Governance and capital allocation | Medium | High | Transparent treatment of all economic owners in any transaction |
| Ordinal rankings are analyst judgments, not quantified default probabilities. | |||
The strongest bullish case is that the brands and network retain customer relevance while management stops buying unprofitable sales. Floral’s contribution resilience is evidence worth taking seriously. BloomNet offers a comparatively attractive services business, and Gourmet has seasonal profit potential that a weak quarter obscures. If better marketing and central-cost discipline work together, even a modest improvement in margin across the remaining sales base can create a meaningful earnings recovery. A well-priced asset transaction could also provide time to execute.
The strongest bearish case is that the company is shrinking faster than its fixed and central costs can adjust. Higher order value masks falling order counts, the cash improvement relies on reducing working capital, and the next financing gives lenders or new investors much of the turnaround’s upside. The reduced impairment charge does not repair customer demand. If the company has to sell a profitable asset to fund loss-making operations, a stronger cash balance may coexist with lower future enterprise value.
Our position falls closer to the bearish case at the snapshot price, but not because every operating initiative is doomed. The evidence does not yet establish that recurring cash generation will cover reinvestment, interest and scheduled principal while protecting the current share base. We will change the call when the operating and financing evidence changes. A short squeeze, an oversold bounce or a favorable transaction rumor can move the price before that evidence arrives; those possibilities are why the conviction remains moderate rather than absolute.
A dated worklist makes the thesis testable.
| Window | Event / evidence | What to record |
|---|---|---|
| Next annual filing, date unconfirmed | FY2026 10-K | Exact face debt, fees, shares, controls, commitments and cash-flow detail |
| Any time after Sep10,2026 | Capital-options announcement | Net cash raised, asset earnings sold, interest, fees and dilution |
| Fall2026; expected, not confirmed | Next quarterly earnings release | Orders, revenue decline, contribution and early holiday funding |
| Holiday2026 / following report | Inventory and customer execution | Seasonal borrowing, returns, markdowns and collection pattern |
| Early2027; expected report window | Holiday-quarter results | Recurring profit and cash conversion after refund effects |
| FY2027 annual release; date unconfirmed | Full-year outcome | Guide delivery and whether FCF turns positive |
| Source: issuer filings; derived measures computed in the saved research model. | ||
The capital review can produce news before the next earnings release, but its timing and outcome are not promised. We will read the terms of any announced transaction rather than treat the announcement itself as a catalyst with a predetermined direction. More liquidity helps the operating business; whether it helps existing equity depends on what was issued or sold to obtain it. The same discipline applies to covenant relief: a longer period to execute is useful, but the economics of execution still have to improve.
The next annual filing is particularly valuable because this packet uses an earnings exhibit for the completed fiscal year and the earlier10-Q for several structural details. That is normal when the print precedes the annual filing, and it is not a reason to invent missing schedules. We will reconcile the principal rollforward and share count to the new balance-sheet notes when they are filed. If those facts differ, the valuation bridge must change before the headline call is reused.
At the following quarterly packet, begin with the signpost table at the top of this page. Grade the prior thresholds with actual numbers, retain the old fair value and quote date for comparison, and explain any change in assumptions. This research packet is the first channel packet for this fiscal period; it does not manufacture a successful historical recommendation record. The purpose of the calendar is accountability, not a prediction that the stock will react positively on each date.
Source numbers, assumptions and unavailable fields remain distinguishable.
| Quarter | Revenue $M | GAAP EPS | Adj EBITDA $M | Cash $M | Debt carrying $M |
|---|---|---|---|---|---|
| FY2024 Q4 | 360.912 | −0.32 | −8.787 | 159.437 | 187.113 |
| FY2025 Q1 | 242.090 | −0.53 | −27.946 | 8.407 | 229.793 |
| FY2025 Q2 | 775.492 | 1.00 | 116.278 | 247.220 | 157.474 |
| FY2025 Q3 | 331.454 | −2.80 | −34.920 | 84.684 | 157.278 |
| FY2025 Q4 | 336.622 | −0.82 | −24.246 | 46.502 | 155.764 |
| FY2026 Q1 | 215.200 | −0.83 | −32.947 | 7.747 | 262.940 |
| FY2026 Q2 | 702.179 | 1.10 | 98.118 | 193.337 | 147.470 |
| FY2026 Q3 | 293.014 | −1.56 | −31.224 | 50.697 | 141.823 |
| FY2026 Q4 | 293.118 | −0.82 | −31.017 | 11.366 | 136.176 |
| Source: issuer filings; derived measures computed in the saved research model. | |||||
| Fiscal year | Revenue $M | OCF $M | Capex $M | FCF $M | SBC $M |
|---|---|---|---|---|---|
| 2024 | 1831.421 | 94.999 | 38.632 | 56.367 | 10.688 |
| 2025 | 1685.658 | −26.363 | 41.463 | −67.826 | 11.891 |
| 2026 | 1503.511 | 18.308 | 31.280 | −12.972 | 11.256 |
| Source: issuer filings; derived measures computed in the saved research model. | |||||
| Period | Primary source | Filing date |
|---|---|---|
| FY2024 Q4 | SEC earnings exhibit | 2024-08-29 |
| FY2025 Q1 | SEC earnings exhibit | 2024-10-31 |
| FY2025 Q2 | SEC earnings exhibit | 2025-01-30 |
| FY2025 Q3 | SEC earnings exhibit | 2025-05-08 |
| FY2025 Q4 | SEC earnings exhibit | 2025-09-04 |
| FY2026 Q1 | SEC earnings exhibit | 2025-10-30 |
| FY2026 Q2 | SEC earnings exhibit | 2026-01-29 |
| FY2026 Q3 | SEC earnings exhibit | 2026-05-07 |
| FY2026 Q4 | SEC earnings exhibit | 2026-09-10 |
| Source: issuer filings; derived measures computed in the saved research model. | ||
All reported dollar figures originate in saved SEC filings or the identified market-data provider. The research workspace preserves the raw HTML, complete submissions, JSON responses, source URLs, fetch times and hashes. Source statements use thousands where labeled; this page generally uses millions. Calculations are performed in the saved model rather than typed from memory. The full extracted tables retain below-the-line items, segment figures, adjustment reconciliations and balance-sheet rows beyond the compact presentation above.
GAAP means the financial statements prepared under generally accepted accounting principles. Adjusted EBITDA is the issuer’s supplemental measure, not cash available to shareholders. Segment contribution omits corporate and other expenses. Free cash flow here is operating cash flow less capital expenditures. Enterprise value is modeled equity plus debt less cash under a consistent earnings convention. Working-capital days are endpoint proxies, and historical price windows are descriptive rather than causal. Fair values, scenario probabilities, multiples and cash-flow forecasts are Charged Alpha assumptions.
Data limitations are intentional disclosures, not zeroes. The fiscal2026 annual report has not yet supplied a new employee count or complete structural update. Q4 order/AOV figures are not synthesized from rounded annual totals. Exact current revolving availability and the monthly covenant minimum schedule were not established from the retrieved exhibit. Forward consensus estimates were unavailable from the authorized endpoint. We have not declared VIE exposure absent merely because a text search found no explicit disclosure. The newest individually dated target in the fetched feed is historical, so it is not represented as fresh Street analysis.
The website organizes this packet by ticker and fiscal period so future quarters can be added without replacing the evidence behind this one. Search FLWS at chargedalpha.com for the episode and research history, and use the same signposts to compare later results. Full research packets and the wider stock library are free. Publication links are finalized only after the real episode IDs exist; an empty draft link never stands in for a completed upload.